Forward Pharma A/S EBIT

Forward Pharma A/S (FWP) currently reports a EBIT of $0 as of December 2021. That compares with $1.2B in the prior-year period — down 100.0% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore Forward Pharma A/S's EBIT history and peer comparisons.

Forward Pharma A/S's EBIT decreased from $1.2B to $0 — a 100.0% year-over-year decrease (period ending December 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Forward Pharma A/S's EBIT of $0 is lower than the Healthcare sector average of $23B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Forward Pharma A/S reported $0 in EBIT as of December 2021. That compares with $1.2B in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for Forward Pharma A/S, and consider following FWP for alerts when major investors trade the stock.